Skip to main content

GlossaryDental Implant

Medication-Related Osteonecrosis of the Jaw

MRONJ

It refers to a condition in which exposed jawbone or bone that can be felt through a fistula does not heal for more than 8 weeks in a person who is currently taking or has previously taken bone resorption inhibitors (such as bisphosphonates or denosumab) used for osteoporosis or cancer treatment, either alone or in combination with antiangiogenic agents or immunomodulatory drugs. This diagnosis is made when the patient has not received radiation therapy to the jaw and cancer has not spread to the jawbone.[1]

Standard Term
Medication-Related Osteonecrosis of the Jaw
Common Name
MRONJ
English
Medication-related osteonecrosis of the jaw
Medical Subject Headings (MeSH)
Bisphosphonate-Associated Osteonecrosis of the Jaw Broader Concept

Plain Language Explanation

It is a condition in which exposed jawbone or bone that can be felt through a small opening (fistula) does not heal for a prolonged period in a person who has taken certain medications used for osteoporosis, cancer treatment, or other conditions.

Easily Confused Terms

TermDefinition
Medication-Related Osteonecrosis of the JawA condition in which exposed jawbone or bone that is palpable through a fistula fails to heal for more than 8 weeks in patients who are currently taking or have previously taken bone resorption inhibitors (such as bisphosphonates or denosumab) used to treat osteoporosis or cancer, either alone or in combination with antiangiogenic agents or immunomodulatory drugs.
Peri-ImplantitisPeri-implant diseases are classified into peri-implant mucositis, in which inflammation is confined to the mucosa, and peri-implantitis, in which mucosal inflammation is accompanied by progressive loss of the bone supporting the Dental Implant.

Medication-related osteonecrosis of the jaw is drug-related damage to the jawbone, while peri-implantitis is a condition in which the bone around a Dental Implant is lost due to bacterial inflammation.

Frequently Asked Questions

Paper Q&A That Mention This Term

Evidence List

  1. Ruggiero SL, Dodson TB, Aghaloo T, et al.. American Association of Oral and Maxillofacial Surgeons' Position Paper on Medication-Related Osteonecrosis of the Jaws-2022 Update. J Oral Maxillofac Surg. 2022;80(5):920-943. PMID 35300956 · DOI 10.1016/j.joms.2022.02.008

Read More

This is a description from a public medical information website.

Authorship and Review

Reviewing Clinician
Young Woo SON, Lead DentistD.D.S., Yonsei University College of Dentistry · M.S., New York University (NYU) College of Dentistry · Ph.D. in Prosthodontics, Yonsei University College of Dentistry
Written by
New York Yonsei Dental Clinic Medical Information Editorial Team · Editorial Policy
Literature Review Date
2026.11.01
Clinician Review Date
Displayed after director's review

New York Yonsei Dental Clinic Treatment Guide

Treatments related to medication-related osteonecrosis of the jaw are described in the section below.

Types of Dental Implants

This terminology explanation is for general medical information purposes only and does not substitute for an individual diagnosis. Whether and how to proceed with treatment will be determined after a clinical examination and consultation.

WhatsApp
Quick Consultation